Northrop Grumman to Produce First Hypersonic Glide Phase Interceptor
September 30, 2024 | Northrop GrummanEstimated reading time: 1 minute

The U.S. Missile Defense Agency (MDA) will proceed with Northrop Grumman Corporation for the Glide Phase Interceptor (GPI) program, the first-of-its-kind defensive countermeasure against hypersonic missile threats. Working in close partnership with MDA, the three-year developmental effort produced a purpose-built, innovative design capable of defeating existing and emerging hypersonic threats.
During this next phase of development, Northrop Grumman will:
- Continue to refine the preliminary design of the GPI, which will fire from the U.S. Navy’s Aegis Ballistic Missile Defense destroyers and Aegis Ashore using the standard Vertical Launch System
- Demonstrate system performance in hypersonic environments prior to conducting its Preliminary Design Review
- Complete flight experiments ahead of schedule leveraging the company’s own flight-proven systems
- Use digital engineering practices to connect the entire GPI program to accelerate design processes and develop interceptor capabilities faster and more efficiently
Expert:
Wendy Williams, vice president and general manager, launch and missile defense systems, Northrop Grumman: “GPI adds mission critical standoff to warfighters in scenarios where distance creates an advantage. Tailorable to a multitude of mission requirements, Northrop Grumman’s revolutionary solution is designed to perform in the evolving threat landscape.”
Details:
Northrop Grumman’s design includes advanced technologies, such as a seeker for threat tracking and hit-to-kill accuracy, a re-ignitable upper stage engine used for threat containment and a dual engagement mode to engage threats across a wide range of altitudes.
Northrop Grumman will work closely with the United States in support of its role under the GPI Cooperative Development program with the Japan Ministry of Defense to deliver interceptors to the MDA.
Suggested Items
I-Connect007 Editor’s Choice: Five Must-Reads for the Week
05/09/2025 | Andy Shaughnessy, Design007 MagazineTrade show season is wrapping up as we head into summer. Where has the time gone? I hope you all get the chance to take a vacation this year, because I know you’ve earned one. Speaking of which, when was my last vacay? If I can’t remember, it’s probably time for one. It’s been a busy week in electronics, with fallout from the back-and-forth on tariffs taking up most of the oxygen in the room. We have quite an assortment of articles and columns for you in this installment of Must-Reads. See you next time.
Imec Coordinates EU Chips Design Platform
05/09/2025 | ImecA consortium of 12 European partners, coordinated by imec, has been selected in the framework of the European Chips Act to develop the EU Chips Design Platform.
New Issue of Design007 Magazine: Are Your Data Packages Less Than Ideal?
05/09/2025 | I-Connect007 Editorial TeamWhy is it so difficult to create the ideal data package? Many of these simple errors can be alleviated by paying attention to detail—and knowing what issues to look out for. So, this month, our experts weigh in on the best practices for creating the ideal data package for your design.
RF PCB Design Tips and Tricks
05/08/2025 | Cherie Litson, EPTAC MIT CID/CID+There are many great books, videos, and information online about designing PCBs for RF circuits. A few of my favorite RF sources are Hans Rosenberg, Stephen Chavez, and Rick Hartley, but there are many more. These PCB design engineers have a very good perspective on what it takes to take an RF design from schematic concept to PCB layout.
Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems
05/08/2025 | Cadence Design SystemsAt its annual flagship user event, CadenceLIVE Silicon Valley 2025, Cadence announced a major expansion of its Cadence® Millennium™ Enterprise Platform with the introduction of the new Millennium M2000 Supercomputer featuring NVIDIA Blackwell systems, which delivers AI-accelerated simulation at unprecedented speed and scale across engineering and drug design workloads.